Literature DB >> 16800515

Monte Carlo simulation of cisplatin molecule in aqueous solution.

Juliana Fedoce Lopes1, Victor Ströele de A Menezes, Hélio A Duarte, Willian R Rocha, Wagner B De Almeida, Hélio F Dos Santos.   

Abstract

The Lennard-Jones (12-6) parameters were obtained for all atoms of cisplatin molecule using the ab initio quantum mechanical potential energy surface for the water-cisplatin interaction as reference data. The parameters found were (epsilon/kcal.mol(-1) and sigma/angstroms) 1.0550, 3.6590 (Pt); 0.0381, 4.6272 (Cl); 0.0455, 3.3783 (N); and 0.0185, 0.0936 (H) and provided very good results for the description of the aqueous solution of cisplatin through Monte Carlo simulation. From statistical analysis of solute-solvent interactions, we observed that the NH3 groups are involved in 53% of the calculated hydrogen bonds with a significant contribution from chlorides (41%) and only 6% involving the Pt center. This is in agreement with the expected behavior for such molecules. Two hydration shells with 22 and 81 water molecules, respectively, centered around 4.6 and 7.3 angstroms were found from the center of mass pair correlation function analysis. The cisplatin atomic Lennard-Jones parameters are reported for the first time, and they might be useful for studying the structure, properties, and processes of cisplatin-like molecules in aqueous solution, including explicitly the solvent effect.

Entities:  

Year:  2006        PMID: 16800515     DOI: 10.1021/jp057448c

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  9 in total

1.  Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study.

Authors:  Ondřej Bradáč; Tomáš Zimmermann; Jaroslav V Burda
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

2.  Empirical force field for cisplatin based on quantum dynamics data: case study of new parameterization scheme for coordination compounds.

Authors:  S Yesylevskyy; Bruno Cardey; S Kraszewski; Sarah Foley; Mironel Enescu; Antônio M da Silva; Hélio F Dos Santos; Christophe Ramseyer
Journal:  J Mol Model       Date:  2015-09-19       Impact factor: 1.810

3.  Exploration of various electronic properties along the reaction coordinate for hydration of Pt(II) and Ru(II) complexes; the CCSD, MPx, and DFT computational study.

Authors:  Jaroslav V Burda; Zdeněk Futera; Zdeněk Chval
Journal:  J Mol Model       Date:  2013-10-15       Impact factor: 1.810

4.  Formation of chelate structure between His-Met dipeptide and diaqua-cisplatin complex; DFT/PCM computational study.

Authors:  Michal Maixner; Helio F Dos Santos; Jaroslav V Burda
Journal:  J Biol Inorg Chem       Date:  2018-02-08       Impact factor: 3.358

5.  Activation of the cisplatin and transplatin complexes in solution with constant pH and concentration of chloride anions; quantum chemical study.

Authors:  Tomáš Zimmermann; Jerzy Leszczynski; Jaroslav V Burda
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

6.  Comparison of the electronic properties, and thermodynamic and kinetic parameters of the aquation of selected platinum(II) derivatives with their anticancer IC50 indexes.

Authors:  Ondrej Bradác; Tomás Zimmermann; Jaroslav V Burda
Journal:  J Mol Model       Date:  2008-03-06       Impact factor: 1.810

7.  How can the cisplatin analogs with different amine act on DNA during cancer treatment theoretically?

Authors:  Arezo Rahiminezhad; Mahboube Eslami Moghadam; Adeleh Divsalar; A Wahid Mesbah
Journal:  J Mol Model       Date:  2021-12-07       Impact factor: 1.810

8.  Effects of intermolecular interactions on the stability of carbon nanotube-gold nanoparticle conjugates in solution.

Authors:  Lukasz Konczak; Jolanta Narkiewicz-Michalek; Giorgia Pastorin; Tomasz Panczyk
Journal:  Int J Nanomedicine       Date:  2016-11-07

9.  The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin.

Authors:  Timothée Rivel; Christophe Ramseyer; Semen Yesylevskyy
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.